GLP-1 receptor agonists are established for blood sugar control and weight loss, but research is expanding into areas like IBS, appetite regulation, and PCOS
It also influences the expression of genes involved in tissue repair, including EGR-1 and NAB2, creating cascading effects that persist even after the peptide itself has cleared from the body
Clinical studies reporting variability in lean mass trajectories and dietary intake during GLP-1RAassociated weight loss [40, 75] suggest that adaptive stability may depend not only on receptor-mediated signaling but also on substrate availability during sustained hypophagia
They were initially aimed at treating patients with type 2 diabetes, but some are now developed specifically to treat obesity
Half-Life and Dosing Considerations Melanotan II has a relatively short plasma half-life but exhibits prolonged biological activity often lasting over 30 hours, allowing for flexible dosing schedules but also increasing the risk of prolonged side effects
The association of high stress with sudden hair whitening is questionable